Using a combination of amyloid misfolding status and GFAP levels, the incidence of Alzheimer's disease diagnosis could be accurately predicted 17 years in advance with a receiver-operating characteristic area under the curve of 0.83 (Beyer et al., 2022), paving the way for minimally invasive early detection of cognitive decline. This evidence concerns the gene GFAP and Mental deterioration.